PRESS RELEASE published on 12/08/2025 at 14:53, 5 months 14 days ago EQS-Adhoc: Carl Zeiss Meditec AG: Termination of Maximilian Foerst’s Executive Board mandate as of 31 December 2025 and interim assumption of the CEO role by Andreas Pecher as of 1 January 2026 Carl Zeiss Meditec AG terminates Maximilian Foerst's Executive Board mandate on 31 December 2025 due to Code of Conduct violation. Andreas Pecher named interim CEO from 1 January 2026 Carl Zeiss Meditec AG Maximilian Foerst Andreas Pecher CEO Role Code Of Conduct Violation
BRIEF published on 08/07/2025 at 07:05, 9 months 15 days ago Carl Zeiss Meditec annonce une croissance de son chiffre d'affaires et de ses bénéfices pour 2024/25 Carl Zeiss Meditec Chiffre D'affaires 2024/25 Croissance En Ophtalmologie Ventes De Microchirurgie EMEA Et Amériques
BRIEF published on 08/07/2025 at 07:05, 9 months 15 days ago Carl Zeiss Meditec Reports Revenue and Earnings Growth for 2024/25 Carl Zeiss Meditec 2024/25 Revenue Ophthalmology Growth Microsurgery Sales EMEA And Americas
PRESS RELEASE published on 08/07/2025 at 07:00, 9 months 15 days ago Carl Zeiss Meditec grows revenue and earnings in the first nine months of 2024/25 Carl Zeiss Meditec AG reports revenue and earnings growth in the first nine months of 2024/25 fiscal year, with EBITA rising to €175.4m and positive contributions from various regions Revenue Growth Carl Zeiss Meditec Earnings Growth Fiscal Year 2024/25 Regional Contributions
BRIEF published on 05/13/2025 at 07:05, 1 year ago Carl Zeiss Meditec annonce une croissance de son chiffre d'affaires pour le premier semestre 2024/25 Carl Zeiss Meditec Croissance Des Revenus Ophtalmologie Tarifs Commerciaux Américains Acquisition De DORC
BRIEF published on 05/13/2025 at 07:05, 1 year ago Carl Zeiss Meditec Reports Revenue Growth for First Half of 2024/25 Revenue Growth Carl Zeiss Meditec Ophthalmology DORC Acquisition US Trade Tariffs
PRESS RELEASE published on 05/13/2025 at 07:00, 1 year ago Carl Zeiss Meditec achieves revenue growth and stable operating profit in the first six months of 2024/25 Carl Zeiss Meditec AG achieves revenue growth of 10.9% and stable operating profit in the first six months of 2024/25, with a significant order entry increase of 33.4% Revenue Growth Operating Profit Carl Zeiss Meditec AG Order Entry Increase Fiscal Year 2024/25
BRIEF published on 05/07/2025 at 15:25, 1 year ago Leadership Transition at Carl Zeiss Meditec AG Carl Zeiss Meditec Leadership Change Ophthalmology Maximilian Foerst Dr. Markus Weber
BRIEF published on 05/07/2025 at 15:25, 1 year ago Transition de direction chez Carl Zeiss Meditec AG Carl Zeiss Meditec Changement De Direction Ophtalmologie Maximilien Foerst Dr Markus Weber
PRESS RELEASE published on 05/07/2025 at 15:20, 1 year ago Change of President and CEO at Carl Zeiss Meditec AG Carl Zeiss Meditec AG announces change of President and CEO: Dr. Markus Weber steps down on 31 May 2025, to be succeeded by Maximilian Foerst on 1 June 2025. Foerst is currently Head of ZEISS Greater China Carl Zeiss Meditec AG President CEO Change Maximilian Foerst
Published on 05/22/2026 at 14:04, 2 hours 46 minutes ago Wi2Wi Corporation Announces First Quarter 2026 Financial Results (Unaudited)
Published on 05/22/2026 at 14:00, 2 hours 50 minutes ago Imagine Health Achieves Teaching Facility Status Through University of Calgary Faculty Partnership
Published on 05/22/2026 at 14:00, 2 hours 50 minutes ago CCL Industries Inc. Announces Renewal of Normal Course Issuer Bid and Approval of Automatic Securities Purchase Plan
Published on 05/22/2026 at 14:00, 2 hours 50 minutes ago Dateline Appoints Alvarez & Marsal to Manage Colosseum Development
Published on 05/22/2026 at 14:00, 2 hours 50 minutes ago EQ Inc. Reports First Quarter 2026 Financial Results and Annual General Meeting Results
Published on 05/22/2026 at 16:44, 5 minutes ago 2026 Annual General Meeting of Fresenius: Shareholders approve all agenda items
Published on 05/22/2026 at 16:38, 11 minutes ago SoftwareOne shareholders approve all proposals of the Board of Directors at the 2026 Annual General Meeting
Published on 05/22/2026 at 15:30, 1 hour 19 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 05/22/2026 at 15:30, 1 hour 20 minutes ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc
Published on 05/22/2026 at 12:52, 3 hours 57 minutes ago Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Published on 05/22/2026 at 12:52, 3 hours 57 minutes ago Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026
Published on 05/22/2026 at 08:30, 8 hours 20 minutes ago Eiffage is building four solar power plants for the NOOR Atlas programme in Morocco
Published on 05/22/2026 at 08:30, 8 hours 20 minutes ago Eiffage réalise quatre centrales photovoltaïques dans le cadre du programme NOOR Atlas au Maroc
